Table 1.
Clinical data and PET/CT findings in 31 patients with NSCLC
|
Patient no. |
Age |
Sex |
Pathology |
Tumor diameter (mm) |
TNM classification |
Lymph node staging |
SUVmax |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
|
|
|
|
|
|
|
Primary lung lesion |
Mediastinal positive uptake |
Ascending aorta |
|||
| 4DST | FDG | 4DST | FDG | 4DST | FDG | 4DST | FDG | ||||||
| 1 |
56 |
M |
Adeno |
31 |
pT2aN0M0 |
N0 |
N0 |
4.7 |
10.9 |
- |
- |
0.6 |
1.6 |
| 2 |
79 |
F |
Adeno |
14, 18 |
pT1aN0M0 |
N0 |
N0 |
1.8 to 2.1 |
1.3 to 2.8 |
- |
- |
1.1 |
2.2 |
| 3 |
55 |
F |
Adeno |
18 |
pT1aN0M0 |
N0 |
N0 |
4.1 |
7.7 |
- |
- |
1.0 |
1.7 |
| 4 |
60 |
M |
Adeno |
15 |
pT1aN2M0 |
N2 |
N0 |
1.5 |
1.4 |
1.7 |
- |
0.7 |
1.7 |
| 5 |
69 |
M |
Adeno |
12 |
pT3N1M0 |
N2 |
N2 |
2.7 |
13.7 |
1.9 to 3.1 |
2.0 to 2.7 |
0.6 |
1.6 |
| 6 |
62 |
M |
Adeno |
32 |
pT2aN2M0 |
N2 |
N2 |
3.5 |
7.1 |
1.6 to 3.5 |
2.9 to 3.6 |
0.9 |
1.9 |
| 7 |
77 |
F |
Adeno |
20 |
pT1aN0M0 |
N0 |
N0 |
2.7 |
4.5 |
- |
- |
0.8 |
2.2 |
| 8 |
73 |
F |
Adeno |
15 |
pT2aN0M0 |
N3 |
N3 |
2.7 |
5.2 |
2.7 to 4.4 |
3.6 to 5.8 |
1.0 |
2.1 |
| 9 |
58 |
M |
SCC |
30 |
pT2aN1M0 |
N2 |
N0 |
3.0 |
5.6 |
2.1 to 2.5 |
- |
0.8 |
1.7 |
| 10 |
55 |
M |
Large cell |
62 |
pT2bN1M0 |
N2 |
N2 |
3.2 |
7.6 |
1.9 to 2.0 |
1.7 |
1.0 |
1.8 |
| 11 |
72 |
M |
Adeno |
55 |
pT2bN0M0 |
N1 |
N0 |
4.5 |
10.1 |
3.0 |
- |
0.9 |
2.3 |
| 12 |
74 |
M |
SCC |
30 |
pT2aN0M0 |
N1 |
N1 |
3.9 |
17.3 |
4.2 |
3.1 |
1.0 |
2.1 |
| 13 |
78 |
M |
Adeno |
38 |
pT2aN0M0 |
N0 |
N1 |
4.0 |
6.3 |
- |
2.3 |
0.9 |
2.0 |
| 14 |
73 |
M |
Adeno |
20 |
pT1aN0M0 |
N2 |
N1 |
2.1 |
3.6 |
2.9 to 3.0 |
2.5 to 3.3 |
0.6 |
2.3 |
| 15 |
79 |
M |
Adeno |
19 |
pT1aN0M0 |
N2 |
N0 |
3.0 |
4.2 |
2.4 to 2.6 |
- |
0.7 |
2.1 |
| 16 |
58 |
F |
Adeno |
18 |
pT1aN2M0 |
N2 |
N0 |
1.5 |
3.5 |
3.9 to 4.2 |
- |
0.6 |
2.2 |
| 17 |
54 |
M |
SCC |
32 |
pT2aN0M0 |
N2 |
N0 |
1.6 |
0.8 |
2.2 |
- |
0.7 |
1.6 |
| 18 |
84 |
M |
Adeno |
19 |
pT1aN0M0 |
N0 |
N0 |
1.9 |
1.2 |
- |
- |
0.5 |
2.1 |
| 19 |
76 |
M |
Adeno |
25 |
pT2aN0M0 |
N2 |
N0 |
6.5 |
13.5 |
3.0 to 5.3 |
- |
0.6 |
1.8 |
| 20 |
75 |
M |
Adeno |
42 |
pT2aN2M0 |
N2 |
N0 |
5.2 |
3.6 |
1.7 |
- |
0.7 |
2.0 |
| 21 |
70 |
M |
SCC |
45 |
pT3N1M0 |
N2 |
N0 |
5.6 |
15.7 |
2.8 to 2.9 |
- |
0.4 |
1.7 |
| 22 |
73 |
M |
Large cell |
19 |
pT1aN0M0 |
N2 |
N0 |
2.8 |
4.2 |
1.7 to 2.4 |
- |
0.6 |
1.8 |
| 23 |
76 |
M |
Large cell |
17 |
pT1aN2M0 |
N2 |
N2 |
1.7 |
2.8 |
2.1 to 3.1 |
4.1 to 4.4 |
0.4 |
1.5 |
| 24 |
88 |
M |
SCC |
70 |
pT3N0M0 |
N2 |
N2 |
5.1 |
18.8 |
4.7 to 5.6 |
2.7 to 3.6 |
0.4 |
1.9 |
| 25 |
36 |
F |
Adeno |
21 |
pT1bN0M0 |
N1 |
N1 |
4.4 |
3.3 |
2.9 |
2.7 |
0.7 |
2.0 |
| 26 |
76 |
F |
SCC |
60 |
pT2bN0M0 |
N2 |
N2 |
4.8 |
18.1 |
2.3 to 2.4 |
2.2 to 2.3 |
0.5 |
1.7 |
| 27 |
43 |
F |
Adeno |
28 |
pT2aN0M0 |
N1 |
N0 |
2.4 |
9.3 |
1.6 |
- |
0.9 |
1.9 |
| 28 |
70 |
M |
Adeno |
20 |
T1bN2M1a |
N2 |
N2 |
3.0 |
3.0 |
2.0 to 3.3 |
3.0 |
0.4 |
1.9 |
| 29 |
69 |
F |
Adeno |
22 |
T1aN0M1a |
N3 |
N0 |
2.5 |
2.8 |
1.6, 1.6 |
- |
0.6 |
1.7 |
| 30 |
70 |
M |
Adeno |
37 |
T2aN0M1a |
N3 |
N0 |
4.7 |
12.2 |
2.6 to 4.9 |
- |
0.7 |
2.3 |
| 31 | 61 | F | Adeno | 32 | T2aN2M1a | N2 | N2 | 3.3 | 8.9 | 1.7 to 4.1 | 3.1 | 0.5 | 1.6 |
NSCLC, non-small cell lung cancer; SUVmax, maximum standardized uptake value; M, male; F, female; Adeno, adenocarcinoma; SCC, squamous cell carcinoma; Large cell, large cell carcinoma.